The Experts below are selected from a list of 1041 Experts worldwide ranked by ideXlab platform
Mario Baraldi - One of the best experts on this subject based on the ideXlab platform.
-
urine retention due to intra spinal cord injection of colchicine in rats improved recovery of bladder function by monosialoganglioside gm1 and nerve growth factor administration
Functional Neurology, 1991Co-Authors: Mario Baraldi, M Paro, G Italiano, Paola Zanoli, Claudio Truzzi, Massimo ProsdocimiAbstract:: Intra-spinal cord injection of a low dose of colchicine (2 micrograms/rat) at the lumbar level affects the micturition reflex leading to voiding suppression, bladder hypertrophy and Overflow Incontinence which lasts about four weeks. The administration of nerve growth factor and monosialoganglioside GM1 normalizes urine output within 3 days and improves recovery of the bladder contraction tested by a cystometric analysis.
-
Evidence that bremazocine prevents urine retention induced by intraspinal cord injection of colchicine in rats.
Journal of the autonomic nervous system, 1990Co-Authors: Paola Zanoli, Mario BaraldiAbstract:Intra-spinal cord injection of colchicine (2.5-5 micrograms/rat) produced an inhibition of reflex micturition leading to voiding suppression, bladder hypertrophy and Overflow Incontinence. Intraperitoneal administration of bremazocine, a kappa-receptor agonist with antagonistic properties for mu- and delta-receptors minimized the colchicine induced effects. The selective kappa-receptors agonist, U-69593, had little effect, while eledoisin or naloxone administration worsened rather than counteracted urine retention.
-
Evidence that bremazocine prevents urine retention induced by intraspinal cord injection of colchicine in rats.
Journal of the Autonomic Nervous System, 1990Co-Authors: Paola Zanoli, Mario BaraldiAbstract:Abstract Intra-spinal cord injection of colchicine (2.5–5 μg/rat) produced an inhibition of reflex micturition leading to voiding suppression, bladder hypertrophy and Overflow Incontinence. Intraperitoneal administration of bremazocine, a κ-receptor agonist with antagonistic properties for μ- and δ-receptors minimized the colchicine induced effects. The selective κ-receptors agonist, U-69593, had little effect, while eledoisin or naloxone administration worsened rather than counteracted urine retention.
Massimo Prosdocimi - One of the best experts on this subject based on the ideXlab platform.
-
urine retention due to intra spinal cord injection of colchicine in rats improved recovery of bladder function by monosialoganglioside gm1 and nerve growth factor administration
Functional Neurology, 1991Co-Authors: Mario Baraldi, M Paro, G Italiano, Paola Zanoli, Claudio Truzzi, Massimo ProsdocimiAbstract:: Intra-spinal cord injection of a low dose of colchicine (2 micrograms/rat) at the lumbar level affects the micturition reflex leading to voiding suppression, bladder hypertrophy and Overflow Incontinence which lasts about four weeks. The administration of nerve growth factor and monosialoganglioside GM1 normalizes urine output within 3 days and improves recovery of the bladder contraction tested by a cystometric analysis.
Paola Zanoli - One of the best experts on this subject based on the ideXlab platform.
-
urine retention due to intra spinal cord injection of colchicine in rats improved recovery of bladder function by monosialoganglioside gm1 and nerve growth factor administration
Functional Neurology, 1991Co-Authors: Mario Baraldi, M Paro, G Italiano, Paola Zanoli, Claudio Truzzi, Massimo ProsdocimiAbstract:: Intra-spinal cord injection of a low dose of colchicine (2 micrograms/rat) at the lumbar level affects the micturition reflex leading to voiding suppression, bladder hypertrophy and Overflow Incontinence which lasts about four weeks. The administration of nerve growth factor and monosialoganglioside GM1 normalizes urine output within 3 days and improves recovery of the bladder contraction tested by a cystometric analysis.
-
Evidence that bremazocine prevents urine retention induced by intraspinal cord injection of colchicine in rats.
Journal of the autonomic nervous system, 1990Co-Authors: Paola Zanoli, Mario BaraldiAbstract:Intra-spinal cord injection of colchicine (2.5-5 micrograms/rat) produced an inhibition of reflex micturition leading to voiding suppression, bladder hypertrophy and Overflow Incontinence. Intraperitoneal administration of bremazocine, a kappa-receptor agonist with antagonistic properties for mu- and delta-receptors minimized the colchicine induced effects. The selective kappa-receptors agonist, U-69593, had little effect, while eledoisin or naloxone administration worsened rather than counteracted urine retention.
-
Evidence that bremazocine prevents urine retention induced by intraspinal cord injection of colchicine in rats.
Journal of the Autonomic Nervous System, 1990Co-Authors: Paola Zanoli, Mario BaraldiAbstract:Abstract Intra-spinal cord injection of colchicine (2.5–5 μg/rat) produced an inhibition of reflex micturition leading to voiding suppression, bladder hypertrophy and Overflow Incontinence. Intraperitoneal administration of bremazocine, a κ-receptor agonist with antagonistic properties for μ- and δ-receptors minimized the colchicine induced effects. The selective κ-receptors agonist, U-69593, had little effect, while eledoisin or naloxone administration worsened rather than counteracted urine retention.
Nancy E. Epstein - One of the best experts on this subject based on the ideXlab platform.
-
Surgically confirmed cauda equina and nerve root injury following percutaneous discectomy at an outside institution: a case report.
Journal of Spinal Disorders, 1990Co-Authors: Nancy E. EpsteinAbstract:: A 39-year-old woman sustained a permanent nerve root and cauda equina injury following a left-sided L5-S1 automated percutaneous discectomy (PERC) performed with the Nucleotome at an outside institution. Despite delayed surgery, which included excision of a sequestrated L5-S1 disc on the right and intradural exploration and resultant confirmation of a disrupted cauda equina, S1 radiculopathy, sacral numbness, and Overflow Incontinence persisted. Although PERC using the Nucleotome has been accepted by some as a safe alternative to the surgical management of disc disease, the paucity of similar complications reported in the literature may more closely reflect the medicolegal climate rather than the inherent safety of this technique.
-
Surgically confirmed cauda equina and nerve root injury following percutaneous discectomy at an outside institution: a case report.
Journal of Spinal Disorders, 1990Co-Authors: Nancy E. EpsteinAbstract:: A 39-year-old woman sustained a permanent nerve root and cauda equina injury following a left-sided L5-S1 automated percutaneous discectomy (PERC) performed with the Nucleotome at an outside institution. Despite delayed surgery, which included excision of a sequestrated L5-S1 disc on the right and intradural exploration and resultant confirmation of a disrupted cauda equina, S1 radiculopathy, sacral numbness, and Overflow Incontinence persisted. Although PERC using the Nucleotome has been accepted by some as a safe alternative to the surgical management of disc disease, the paucity of similar complications reported in the literature may more closely reflect the medicolegal climate rather than the inherent safety of this technique.
Roger R. Dmochowski - One of the best experts on this subject based on the ideXlab platform.
-
Urinary Retention in Women
2000Co-Authors: Roger R. DmochowskiAbstract:By definition, the woman afflicted with urinary retention is unable to completely empty her bladder. However, it is difficult to characterize the condition of urinary retention on the basis of the magnitude of residual volume alone, and more important to evaluate and render treatment for the presenting symptomatic complex and any associated urinary tract pathophysiology. Retention may be symptomatic or asymptomatic. Symptoms commonly associated with retention may include pure irritative (urgency, frequency), or obstructive (incomplete, bladder emptying, hesitancy) components, with or without abdominal or suprapubic discomfort, and urinary Incontinence (either due to Overflow Incontinence or detrusor overactivity). Urinary tract sequellae associated with retention include: alterations in bladder storage characteristics such as compliance changes, which result in abnormal bladder filling pressures, detrusor overactivity, abnormalities in bladder sensation, and effects on renal function owing to abnormal vesical storage pressures and/or recurrent urinary tract infection.
